| Name | BRM/BRG1 ATP Inhibitor-4 | 
|---|
| Description | BRM/BRG1 ATP Inhibitor-4 is a BRG1/BRM inhibitor. BRM/BRG1 ATP Inhibitor-4 can be used for the research of cancers and BAF complex-related disorders[1]. | 
|---|---|
| Related Catalog | |
| In Vivo | BRM/BRG1 ATP Inhibitor-4 (QD; 5, 15, 50 mg/kg) leds to tumor growth inhibition in a dose-dependent manner[1]. Animal Model: Nude mice[1] Dosage: 5, 15, 50 mg/kg Administration: QD Result: Inhibited tumor growth and the size of tumors in mice engrafted with uveal melanoma cell lines. | 
| References | 
                                 [1]. Kevin J. Wilson, et al. Compounds and uses thereof. Patent. WO2021155320A1.  | 
                        
| Molecular Formula | C25H32N6O3S | 
|---|---|
| Molecular Weight | 496.62 |